BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) Files An 8-K Results of Operations and Financial Condition
Item 2.02
|
Results of Operations and Financial Condition. |
On March 9, 2017, BioLife Solutions, Inc. (the Company) issued a
press release announcing the financial results and operational
highlights for the fourth quarter and full year 2016. A copy of
the press release is furnished as Exhibit 99.1 to this current
report on Form 8-K.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits |
| ExhibitNo. | Description | |
| 99.1 | Press release, dated March 9, 2017 |
About BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS)
BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company’s product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service. BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) Recent Trading Information
BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) closed its last trading session up +0.03 at 2.24 with 59,572 shares trading hands.